Biotech & Health
Roche Acquires PathAI, Betting Big on AI Early Disease Detection
Roche is set to acquire PathAI for an upfront payment of $750 million, with potential milestone payments pushing the total past $1 billion, The Wall Street Journal reports.
Juliana Campos·May 18, 2026
